Life Insurance
Consensus Index

AI Consensus Fit Review

Banner Life Insurance After a Heart Attack Fit Review

Banner Life is a conditional fit for Life Insurance After a Heart Attack.

Research: 2026-09-227 usable platform responsesRead the methodology ↗

Share

Answer Capsule

Banner Life is a conditional fit for Life Insurance After a Heart Attack. Five of the seven platforms in this study named Banner Life during the ranking stage, and all seven evaluated it for this use case. The strongest reason to consider it is Banner's fully underwritten OPTerm term product, which permits substandard table ratings and, according to independent broker sources, calculates rated premiums from a Standard Plus baseline that can reduce the cost of a cardiac rating. The main limitation is that Banner's public materials confirm a six-month decline or postponement point for a heart attack but do not disclose the full post-six-month cardiac underwriting schedule, so no applicant can predict approval or pricing before individual underwriting.

Research Snapshot

FieldDetail
Platform mentions in ranking stage5 of 7 platforms (anthropic, deepseek, google, grok, kimi)
Share of included platform responses71.4%
Average listed rank3.6
Best listed rank3
Relevant product/model/planBanner OPTerm fully underwritten term life; Life Step UL for permanent coverage
Overall use-case fitGood, but conditional (platform fit ratings ranged from strong to mixed)
Research date2026-09-22

Why Banner Life Qualified for This Study

Questions This Section Answers

  • Why did Banner Life qualify for this life insurance after a heart attack study?
  • Is Banner Life a legitimate carrier for a heart attack survivor, or just a lead-generation brand?

Banner Life qualified because five of the seven platforms named it during ranking discovery, and all seven platforms then evaluated it for the heart-attack use case. Banner life insurance Company, marketed as Legal & General America, is a licensed U.S. life insurer that sells term life insurance and states it has been helping families protect their financial future since 1949 [1]. It is not a lead-generation brand.

The qualification threshold for this study was at least two platform mentions. Banner Life cleared it with five, appearing at rank 3 or 4 on every platform that named it. Its inclusion rests on a real, fully underwritten product set — OPTerm term life and Life Step UL — rather than on marketing claims alone.

One normalization note matters for transparency: official-site retrieval failed for at least one mention during ranking normalization, so identity details should be verified directly with the carrier [1]. The deterministic identity audit also collapsed company-name variants onto one canonical brand before minimum-mentions qualification.

The Product, Model, Plan, or Service Most Relevant to Life Insurance After a Heart Attack

Questions This Section Answers

  • Which Banner Life plan is most relevant for a buyer who had a heart attack?
  • Does Banner OPTerm require a medical exam for someone with cardiac history?

The most relevant Banner Life product for this use case is OPTerm, a fully underwritten level term life policy. OPTerm provides level premiums and death benefits during the initial term period, with available durations of 10, 15, 20, 25, 30, 35, and 40 years based on eligibility, and issue ages generally 20 through 75 subject to duration and underwriting-class restrictions [2]. Coverage is renewable to age 95 [4].

OPTerm is fully underwritten, meaning Banner reviews medical screenings, medical history, lifestyle, and other information, with medical exams often required [5]. Banner's digital application may use electronic health records, an attending physician statement, or recent lab results instead of a paramedical exam in some cases [6], but a heart-attack history should not be assumed to qualify for no-exam treatment.

Banner's accelerated underwriting eligibility materials explicitly list heart attack or heart (cardiac) disease as an excluded condition for the accelerated path, even though OPTerm is otherwise included in accelerated underwriting eligibility [7]. Banner's underwriting guide also indicates an attending physician statement is always required for applicants over age 60 [9].

Life Step UL, Banner's universal life product, may be considered when permanent coverage is needed, and OPTerm can be exchanged for a universal life policy issued at the same underwriting class as the existing term policy [2]. Banner does not offer whole life insurance [11].

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about Banner Life for life insurance after a heart attack?
  • Is Banner Life's six-month heart attack rule consistent across sources?

The platforms agreed on three points: Banner Life is a real fully underwritten carrier, a recent heart attack blocks the fast underwriting path, and Banner's public materials do not disclose enough cardiac detail to predict an offer.

On the six-month rule, agreement was strong. Banner's January 2026 underwriting field guide lists heart attack or myocardial infarction within six months among decline or postpone situations [12]. Google's review of the same field guide states a heart attack within six months is a decline or most likely decline [13]. Grok reported the same six-month postponement point through a broker-hosted copy of Banner's underwriting guidelines [15].

On accelerated underwriting, agreement was unanimous among the platforms that addressed it. A history of heart attack or cardiac disease makes an applicant ineligible for Banner's accelerated, no-exam path [16]. This means a post-heart-attack buyer should expect full medical underwriting, an exam, labs, and medical records review rather than a simplified decision.

On table ratings, the platforms agreed Banner can issue substandard coverage. Current OPTerm specifications state that substandard classifications may be available through Table 12 on Standard Plus and Standard Tobacco classes, subject to underwriting discretion [19]. Grok reported the same Table 12 ceiling [20]. One broker source went further, describing table ratings from Table 1 to Table 16 with possible reconsideration to a better class, but that is a broker statement rather than a Banner-published guarantee [21].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • How much can Banner Life's table rating structure actually save a heart attack survivor?
  • Is Banner Life or another carrier the better starting point for a heart attack case?

The platforms disagreed on how favorable Banner's cardiac underwriting really is, and the disagreement is material for a buyer.

Anthropic rated Banner a strong fit, citing independent sources that Banner explicitly specializes in cardiac underwriting and lists "all heart and cardiac related cases" among areas where underwriting "shines" [22]. The same platform reported that Banner's substandard premium calculations are based on Standard Plus rates rather than Standard, producing savings of $32–46 per month, or $7,680–11,040 over policy life, for a Table 3 or higher applicant [23]. Banner's own product information confirms that premiums for table-rated policies are based on the Standard Plus underwriting class [25], which supports the mechanism even though the dollar savings figures come from a third-party review.

Deepseek rated Banner a mixed fit and flagged the sourcing problem directly: the strongest cardiac claims come from a brokerage marketing its own services, and no Banner-published or independently confirmed cardiac underwriting guideline, cardiac rate table, or best-case class was located [26]. Perplexity also rated Banner mixed, noting that no verified quote or consumer-facing underwriting matrix for post-heart-attack applicants was found [27].

Kimi added a different caution: independent sources more frequently mention Prudential and Transamerica for heart attack cases specifically, while Banner is more often recommended for bypass surgery cases [29]. That is a ranking difference, not proof that Banner performs worse, but it is a reason to compare offers rather than assume Banner is the best starting point.

Two conflicts remain unresolved. First, the table rating ceiling: Banner's own specifications state Table 12 [30], while a broker source states Tables 1–16 [26]. Second, the conversion window: one source describes conversion during the first 10 years or until age 70, whichever comes first [31], while Banner's current specifications limit conversion to the guaranteed level-premium period or attained age 70, whichever comes first, with policies issued at age 66 or older convertible during the first five policy years [30]. These are broadly consistent but not identical, and the delivered policy controls.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What features does Banner OPTerm offer a buyer with a cardiac history?
  • Does Banner Life offer a conversion option if my heart condition worsens?

Banner OPTerm's most relevant features for a heart-attack survivor are its table-rating capacity, its term-duration range, and its conversion right.

On table ratings, OPTerm permits substandard classifications through Table 12 on Standard Plus and Standard Tobacco classes, subject to underwriting discretion, with premiums increasing by 25% per table rating [32]. Independent sources describe Banner as competitive for single-vessel disease, single-vessel angioplasty, and other mild-to-moderate, well-controlled conditions [33], and as very competitive for individuals with a single health impairment [34].

On conversion, Banner states that OPTerm can be exchanged for a universal life policy issued at the same underwriting class as the existing term policy [35]. Current specifications limit conversion to the guaranteed level-premium period or attained age 70, whichever comes first [32]. One competitor, Protective Life, allows conversion for the full term length, which is longer than Banner's window [36].

On underwriting credits, Google reported that Banner offers a credit program that can improve an applicant's rate by one underwriting class if they meet three of seven favorable health criteria, such as recent normal cardiac testing and a cholesterol ratio under 4.5 [37]. This is a platform-reported finding from an independent review site, not a Banner-published document located in this study.

On financial strength, independent reviews report Banner Life holds an A+ rating from A.M. Best, AA- from S&P Global, and AA- from Fitch, with a NAIC complaint index consistently below the industry average [38]. These are third-party ratings, not Banner claims, and they speak to claim-paying capacity rather than to cardiac underwriting appetite.

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does Banner Life cost per month for a heart attack survivor, and what fees apply?
  • What contract terms should a buyer confirm before signing a Banner OPTerm policy?

No applicant-specific premium for a post-heart-attack buyer can be verified from public information. Banner publishes rate structures and product charges but requires underwriting to determine the final premium, and a prior heart attack could result in a standard, table-rated, postponed, or declined outcome [40].

The published cost components that are verifiable are these. Banner OPTerm carries a $90 annual policy fee [41]. Published modal factors include semiannual 0.51, quarterly 0.26, and monthly EFT 0.085 applied to the annual premium [41]. Substandard premiums are increased by 25% per table rating under the published OPTerm specifications, and table-rated premiums are based on the Standard Plus underwriting class [41]. One platform noted that Banner waives the policy fee on second and subsequent term policies on the same life, but that is a platform-reported detail from an independent review rather than a Banner document located here.

Contract terms to verify include the level premium period, which is guaranteed for the selected term, after which premiums may increase and coverage may reduce [41]. Two-year contestability and suicide provisions apply, with state variations [41]. A free-look period and state-specific cancellation rights should be confirmed in the delivered policy; the reviewed sources did not establish one uniform period [41].

Pricing confidence across platforms was low to moderate. Deepseek reported low confidence and stated that no Banner-published price for post-heart-attack applicants was found [44]. Perplexity also reported low confidence and noted that a policy fee found in search results applied to a different product, FlashTerm, and should not be assumed to apply to OPTerm [45]. Anthropic reported high confidence in Banner's general rate competitiveness but its sample rates were for healthy applicants, not cardiac cases.

Best Suited For

Questions This Section Answers

  • Who is Banner Life best suited for after a heart attack?
  • Is Banner OPTerm worth it for a buyer expecting a Table 3 or higher rating?

Banner Life is best suited for a heart-attack survivor whose event was more than six months ago, whose current cardiac condition is stable, and who expects a table rating rather than a standard offer.

The platforms converged on a similar profile. Anthropic described the best fit as applicants 2–5 years post-event with excellent health markers, including controlled cholesterol, blood pressure, no complications, and good stress test results [46]. Grok described applicants 12–24+ months post-myocardial infarction with ejection fraction above 45%, good stress tests, and controlled metrics expecting table ratings [47]. OpenAI described applicants seeking fully underwritten term coverage after a sufficiently stable recovery period, who may receive a table-rated offer and need relatively high term coverage amounts [48].

The common thread is that Banner's advantage is strongest where a rating is likely. Independent sources state that if an applicant's condition puts them at Table 3 or higher, Banner Life should always be included in a comparison due to its favorable table rating structure [49]. Kimi similarly reported that OPTerm is noted as particularly valuable for applicants expecting table ratings of 3 or higher [50].

Banner is also suited to buyers who want long term durations. Independent reviews describe Banner as consistently among the lowest-cost carriers for fully underwritten level term life insurance, particularly on 30-year and 40-year terms [51].

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose Banner Life for life insurance after a heart attack?
  • Does Banner Life decline applicants whose heart attack was within six months?

Banner Life is probably not the best fit for four buyer profiles, and the platforms agreed on most of them.

First, a buyer whose heart attack occurred within the last six months. Banner's underwriting field guide lists heart attack or myocardial infarction within six months among decline or postpone situations [52]. This is the clearest limitation in the entire evidence set and it comes from Banner's own document.

Second, a buyer who needs guaranteed-issue or simplified-issue coverage because traditional underwriting is likely to produce a postponement, decline, or unaffordable rating [52]. Banner does not offer whole life insurance [54], and its permanent options are limited to universal life products that independent sources describe as credible but not the primary focus of the portfolio [55].

Third, a buyer with multiple impairments. Independent sources state Banner is very competitive for individuals with a single health impairment but that other companies are often compared when dealing with combination impairments such as heart disease and diabetes [56].

Fourth, a New York resident. Banner products are distributed in 49 states and the District of Columbia, and Banner states that it is not an authorized New York insurer and does not do business in New York [59].

One additional caution applies to tobacco users. Independent reviews report that Banner's rates are less competitive for smokers, with State Farm, Penn Mutual, and Pacific Life offering lower premiums [60].

When Another Option May Be Better

Questions This Section Answers

  • What is a better alternative to Banner Life for a buyer whose heart attack was under six months ago?
  • When should a heart attack survivor choose a guaranteed-issue policy instead of Banner OPTerm?

Another option may be better in five situations, and the platforms named specific alternatives for each.

For a very early application, Lincoln Financial is described as most aggressive on timing and willing to consider cases at three months post-heart attack if recovery is exceptional [61]. Grok also named Lincoln Financial for recent myocardial infarction under 12 months.

For complex or multiple impairments, Transamerica and Corebridge Financial have underwriting teams willing to work complex files with multiple cardiac events or combination conditions [62]. Kimi reported that Prudential and Transamerica are more frequently mentioned as primary options for heart attack cases specifically [63].

For buyers who cannot complete full underwriting, guaranteed-issue products are the alternative. One platform cited Mutual of Omaha's guaranteed-issue structure with waiting periods for ages 45–85 as an option for recent events, severe conditions, or multiple declines [64]. A laddered strategy — guaranteed issue now plus fully underwritten coverage later — was also suggested for buyers who need immediate coverage.

For buyers who need permanent coverage, a permanent product from another carrier may be better when lifetime coverage is the primary objective and OPTerm's conversion window or term duration is unsuitable. Banner does not offer whole life [65].

For buyers who want conversion rights across the full term, Protective Life allows conversion for the full term length, longer than Banner Life [66].

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with Banner Life before signing an OPTerm contract?
  • What cardiac records will Banner Life require for a post-heart-attack application?

The platforms produced overlapping verification lists. The consolidated questions a buyer should ask Banner or an independent broker are these.

How many months after this specific heart attack will Banner consider a formal application rather than postpone it ? What medical records are required, including hospital discharge records, cardiologist notes, echocardiogram or ejection-fraction results, stress testing, catheterization or stent records, and current laboratory results ? How would Banner classify the applicant based on event date, age at event, number of vessels affected, treatment, current heart function, recurrence history, medications, tobacco use, blood pressure, cholesterol, diabetes, and weight ?

Would the case be considered for Standard, Table 1 through Table 12, flat extra, postponement, or decline ? Does the quoted premium include the $90 annual policy fee and the selected payment-mode factor ? Is OPTerm available in the applicant's state and for the requested face amount and term duration ?

What exact conversion rights apply, and what universal-life products are available for conversion ? Would an informal, non-binding pre-underwriting review avoid creating an unfavorable formal application record ? Are any exam, laboratory, medical-record, or inspection costs charged to the applicant ? What free-look, contestability, suicide, lapse, reinstatement, and cancellation provisions apply in the applicant's state ?

One platform added a question about whether Banner offers reconsideration if cardiac risk factors improve. A broker source states that some table-rated policies may be reconsidered for a better class if health improves, but the exact terms are not confirmed on Banner's site [67].

Final AI Consensus Verdict

Banner Life is a good but conditional fit for life insurance after a heart attack. Five of seven platforms named it during ranking, and all seven evaluated it. Platform fit ratings ranged from strong (anthropic) to good (openai, grok, kimi) to mixed (deepseek, google, perplexity), which is a spread rather than a consensus.

The strongest supported reason to consider Banner is its fully underwritten OPTerm product with substandard availability through Table 12 and table-rated premiums calculated from a Standard Plus baseline [68]. The strongest supported reason to hesitate is that Banner's public materials confirm a six-month decline or postponement point but do not disclose the full post-six-month cardiac underwriting schedule, and no reliable applicant-specific premium or acceptance probability was publicly available [70].

A multi-carrier comparison is advisable. Banner's public information does not reveal enough cardiac underwriting detail to establish that it will offer the best rate or approval outcome, and independent sources more frequently name Prudential and Transamerica for heart attack cases specifically [71]. Banner is a weak fit for a recent event, an unstable cardiac condition, a New York resident, or a buyer who needs guaranteed acceptance.

How This Review Was Produced

This review was produced from seven AI platform responses collected for the topic "Best Life Insurance After a Heart Attack" under the category life insurance. Each platform was asked which life insurance carriers are generally worth considering after a heart attack and why. Banner Life was one of the carriers evaluated.

The study used a ranking stage and a fit-research stage. In the ranking stage, five of seven platforms named Banner Life. In the fit-research stage, all seven platforms produced a structured assessment covering product relevance, underwriting factors, pricing, limitations, alternatives, and verification questions. Platform fit ratings, pricing figures, and product details were taken from those responses and are cited inline.

The consensus index for this topic is Life Insurance After a Heart Attack, which lists all carriers evaluated under the same methodology.

Methodology Limitations

Several limitations apply to this review and should be weighed before acting on it.

Platform-reported research dates differ from the authoritative run date of 2026-09-22. Deepseek reported a research date of 2026-02-14, while the other six platforms reported 2026-09-22. Platform-reported dates are provenance metadata and do not independently prove freshness.

The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Citations are platform-reported evidence, not independently verified facts. Claims without a retrieved citation are labeled platform-reported or unverified in the text.

Banner's public materials confirm a six-month decline or postponement point for heart attack but do not disclose the full post-six-month underwriting schedule. The reviewed Banner sources do not verify how specific cardiac measurements, procedures, medications, or risk-factor control affect classification. Banner's public product materials describe accelerated underwriting generally but do not guarantee that a prior heart attack will qualify for an accelerated decision.

Published product specifications and rates can change by state, product version, and effective date; the current policy form and illustration control. No reliable applicant-specific premium or acceptance probability was publicly available.

One platform (deepseek) ran without search enabled, so its claims rest on model knowledge plus the sources it cited rather than live retrieval. Its cardiac-specific claims should be treated with additional caution.

The deterministic identity audit noted that official-site retrieval failed for one or more mentions during ranking normalization, and that company-name variants were collapsed onto one canonical brand before minimum-mentions qualification. The official-page excerpt retrieved for bannerlife.com was marked retrieved_not_verified.

AI-platform agreement does not prove product quality. Agreement here means multiple platforms described the same published Banner documents or the same independent broker commentary; it does not mean Banner will approve any particular applicant or offer a competitive rate.

Sources

Company-Owned Sources

Independent Sources

Other Sources

  • Additional AI research evidence71 records
    1. AI research evidence record deepseek:c1
    2. AI research evidence record openai:c6
    3. AI research evidence record anthropic:opterm-age-range
    4. AI research evidence record anthropic:opterm-renewal-to-95
    5. AI research evidence record openai:c2
    6. AI research evidence record openai:c3
    7. AI research evidence record perplexity:c3
    8. AI research evidence record perplexity:c4
    9. AI research evidence record perplexity:c2
    10. AI research evidence record anthropic:opterm-conversion-feature
    11. AI research evidence record anthropic:no-whole-life-offered
    12. AI research evidence record openai:c1
    13. AI research evidence record google:2.1.1
    14. AI research evidence record google:2.1.9
    15. AI research evidence record grok:4
    16. AI research evidence record perplexity:c3
    17. AI research evidence record google:1.1.2
    18. AI research evidence record google:2.1.2
    19. AI research evidence record openai:c4
    20. AI research evidence record grok:1
    21. AI research evidence record deepseek:c2
    22. AI research evidence record anthropic:banner-cardiac-shines
    23. AI research evidence record anthropic:banner-table-savings
    24. AI research evidence record anthropic:banner-standard-plus-baseline
    25. AI research evidence record openai:c5
    26. AI research evidence record deepseek:c2
    27. AI research evidence record perplexity:c3
    28. AI research evidence record perplexity:c4
    29. AI research evidence record kimi:mozdex-cardiac
    30. AI research evidence record openai:c4
    31. AI research evidence record anthropic:banner-conversion-10years-70
    32. AI research evidence record openai:c4
    33. AI research evidence record anthropic:banner-mild-moderate-cardiac
    34. AI research evidence record anthropic:banner-single-impairment-strong
    35. AI research evidence record openai:c6
    36. AI research evidence record anthropic:protective-full-term-conversion
    37. AI research evidence record google:1.2.5
    38. AI research evidence record anthropic:banner-financial-ratings
    39. AI research evidence record anthropic:banner-complaint-ratio
    40. AI research evidence record openai:c8
    41. AI research evidence record openai:c4
    42. AI research evidence record grok:1
    43. AI research evidence record openai:c5
    44. AI research evidence record deepseek:c2
    45. AI research evidence record perplexity:c3
    46. AI research evidence record anthropic:banner-healed-cardiac-best
    47. AI research evidence record grok:0
    48. AI research evidence record openai:c1
    49. AI research evidence record anthropic:banner-table-3-plus
    50. AI research evidence record kimi:dglifegroup-cardiac
    51. AI research evidence record anthropic:banner-30-40-year-lowest
    52. AI research evidence record openai:c1
    53. AI research evidence record google:2.1.1
    54. AI research evidence record anthropic:no-whole-life-offered
    55. AI research evidence record anthropic:banner-permanent-credible-not-primary
    56. AI research evidence record anthropic:banner-single-impairment-strong
    57. AI research evidence record anthropic:banner-combination-impairment-weaker
    58. AI research evidence record google:1.1.8
    59. AI research evidence record openai:c4
    60. AI research evidence record anthropic:banner-smoker-rates-less-competitive
    61. AI research evidence record anthropic:lincoln-early-3months
    62. AI research evidence record anthropic:transamerica-corebridge-multi-condition
    63. AI research evidence record kimi:mozdex-cardiac
    64. AI research evidence record kimi:mutualofomaha-heart-attack
    65. AI research evidence record anthropic:no-whole-life-offered
    66. AI research evidence record anthropic:protective-full-term-conversion
    67. AI research evidence record deepseek:c2
    68. AI research evidence record openai:c4
    69. AI research evidence record openai:c5
    70. AI research evidence record openai:c1
    71. AI research evidence record kimi:mozdex-cardiac

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 22, 2026
Platforms analyzed
7
Source records
40
Ranking mentions
5 of 7
Platform share
71%
Final consensus rank
#4

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

22 independent · 17 company-owned · 1 unclear

Evidence support

33 direct · 6 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

514c456cc5729adb91b36baeab0a63c4bf570836bdce12191659b9e31aa32d9b